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Purpose: Impaired apoptosis could play an important role in the
development of pannus invasive observed in osteoarthritis (OA)
patients. Pro-inﬂammatory cytokines are particularly important in
the pathophysiology of OA.
This study addresses the effects of tumour necrosis factor α
(TNFα) and interleukin-1β (L-1β) on apoptotic pathways in human
synoviocytes cells.
Methods: Cultured synovial ﬁbroblasts were obtained from 20
patients who were undergoing hip joint replacement. Cell viability,
apoptosis and nuclear morphology were evaluated using the 3-
[4,5-dimethylthiazol-2yl] 2,5-diphenyl tetrazolium bromide (MTT)
assay, ﬂow cytometry (propidium iodide) and 4’,6’-Dianidino-2-
phenylindole dihidrochloride (DAPI) stain, respectively. The ex-
pression levels of bcl-2, caspase-7 and -3 were assessed by
western-blot and activation of caspase-3 was measured by ﬂow
cytometry. Ro 31-8220 (Ro, 10 µM) were used to induce apop-
tosis in synoviocytes. Caspase and cyclooxigenase inhibitors
were employed to evaluate the participation of caspases and
prostaglandins (PGs) on apoptotic pathways in human synovio-
cytes cells.
Results: As cell viability was not modiﬁed by TNFα or IL-1β
in cultured synoviocytes, we employed Ro as a model to fa-
cilitate cell death. We demonstrated that the increase of cell
death induced by Ro was ampliﬁed by TNFα but not by IL-1β
in a time dependent manner (at 24 hours, Ro: 4.88±0.06%;
TNFα+Ro: 31.15±2.56%; IL-1β+Ro: 5.15±0.92%). Furthermore,
nuclear morphological typical of apoptosis was more widespread
in the cells treated with TNFα+Ro. Similarly, western blot stud-
ies indicated that IL-1β+Ro did not induce the time-dependent
activation of caspase-7 and -3 observed with TNFα+Ro. In agree-
ment, comparable results were obtained when active fragment
of caspase-3 was evaluated by cytometry (at 24 hours, Ro:
1,93±0,81%; Ro+IL-1β: 2,80±1,13%; Ro+TNFα: 9,56±4,04%).
These different effects were not due to bcl-2 levels. Preincubation
for two hours with caspase inhibitors (-3, -3/7, -8 and general)
signiﬁcantly decreased the percentage of apoptotic cells treated
with TNFα+Ro (2.73±1.34%, 10.0±10.09%, 2.66±0.87%, and
3.3±1.46% with caspase-3, -3/7, -8 and general inhibitor, re-
spectively, n=3, p<0,0001). Similarly, when caspase-3 activation
was evaluated by western blot, it was found that preincubation of
caspase-8 inhibitor was effective to prevent caspase-3 induced
by TNFα+Ro. Finally, this difference seems to be prostaglandin
independent since it was unmodiﬁed by NSAID presence.
Conclusions:Our results suggest that apoptosis of synoviocytes
is differentially regulated by TNFα and IL-1β and this difference
is independent on PGs levels. These data could be important for
a better understanding of the participation of TNFα and IL-1β in
the OA pathogenesis.
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Purpose: The molecular basis of OA pathogenesis is incom-
pletely understood. However, biological stimuli such as cytokines
and growth factors have been recognized to play regulatory roles
in the pathogenesis of this disease. Action of these bioactive
molecules in the affected and surrounding tissues is a conse-
quence of biomechanical stress and other physiological trauma
and pain, which ultimately lead to cartilage degradation and
osteophyte formation. The matrix of normal mature cartilage is
preserved by the articular chondrocytes which maintains a bal-
ance between the matrix synthesizing and degrading activities.
When cartilage matrix receives degenerating insults, such as in-
jury and/or changes in the levels of cytokines and growth factors,
this balancing activity is disturbed. At the early stages of OA, in
an attempt to repair the cartilage matrix, proliferative activities in
the chondrocytes are increased and such proliferation leads to
the formation of so-called “chondrocyte clusters” that have high
metabolic activity. Thickening of the cartilage matrix is an out-
come of such effort. As the disease progresses, articular surface
becomes irregular and formation of vertical clefts, deep ulcera-
tion of the matrix, loss of cartilage, hypertrophy of subchondral
bone and new bone formation at the joint margins (osteophytes)
are seen. During these biological events many intracellular ac-
tivities are modulated. One of the critical cellular processes that
undergo changes is the transcriptional activity. This early event in
the involved tissue and cell has been the subject of intense inves-
tigation because understanding this particular molecular event in
the affected tissue and cell may lead to new therapeutic interven-
tion for OA. In recent studies, SAF-1, an inﬂammation-responsive
transcription factor has been identiﬁed as a transcriptional reg-
ulator of increased synthesis of two matrix degrading MMPs, -1
and -9 and VEGF under arthritic condition. Altered activity of
SAF-1 transcription factor in OA cartilage and in the osteophytes
may provide a clue to its role in the pathogenesis of OA.
Methods: Cartilage tissues from human patients with moderate
to late stages of OA were obtained during total joint replace-
ment surgery. The severity of OA was categorized in three
stages (early, moderate and severe). The normal cartilage tissue
was obtained from cadaver. Cellular localization of SAF-1 was
examined by immunohistochemistry and Western immunoblot
analyses. SAF-1 mRNA level and DNA binding activity were
evaluated by RT-PCR analysis of RNA and electrophoretic mobil-
ity shift assay using nuclear extracts prepared from normal and
OA cartilage tissues. Chromatin immunoprecipitation assay was
performed to assess the engagement of SAF-1 to the promoter
region of several target genes that are associated with cartilage
degradation and osteophyte formation.
Results: Immunohistochemical, DNA-binding and RT-PCR anal-
yses showed higher than normal level of SAF-1 in degenerated
OA cartilage. At early stages of OA, SAF-1 upregulation was
limited in the ﬁbroblast-like cells. In moderate to severe stages
of OA, strong SAF-1 signal was seen in individual and clustered
chondrocytes near the ﬁssure and chondrocytes at the deep
layer of cartilage. In the osteophytes, high level of SAF-1 was
detected in the chondrocytes at the proliferative and hypertrophic
zones and in the microvessels at the newly formed bone-cartilage
interface.
Conclusions: Increased expression and high activity of SAF-1
in cartilage and in osteophytes indicate for a novel dual regula-
tory role of this transcription factor involving both the cartilage
degradation and the reinitiation of bone formation.
